People lost more weight on Zepbound
Digest more
1d
MedPage Today on MSNZepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial.
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among demographic groups, but may in fact be widening them.
President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less than Americans do